Efficacy of multimodal anticancer therapy in the course of pancreatic neuroendocrine carcinoma

Ítems similars

• Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour — the first manifestation of von Hippel-Lindau disease in a young patient
  per: Karolina Morawiec-Sławek, et al.
  Publicat: (2021-08-01)
• Efficacy of multimodal anticancer therapy in the course of pancreatic neuroendocrine carcinoma
  per: Helena Zwinczewska, et al.
  Publicat: (2021-04-01)
• Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
  per: Anna Sowa-Staszczak, et al.
  Publicat: (2021-11-01)
• Comparison of [18F]fluorodeoxyglucose and [68Ga]Gallium DOTA-TATE in patients with active giant cell arteritis
  per: Alison H. Clifford, et al.
  Publicat: (2025-03-01)
• Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology
  per: Monika Liguz-Lecznar, et al.
  Publicat: (2022-02-01)